Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2300044	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2023-10-09					view
JYSZ2300043	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2023-10-09					view
JYSZ2300042	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2023-10-09					view
JYSZ2300045	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2023-10-09					view
JYSB2100068	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSB2100067	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSB2100066	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSB2000323	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2020-06-29	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2020-07-01	view
JYSB2000322	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2020-06-29	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2020-07-01	view
JYSB2000324	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2020-06-29	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2020-07-01	view
JYSF1900021	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2019-12-03	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-12-19	view
JYSB1900331	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2019-11-26	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2019-12-10	view
JYSZ1900020	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSZ1900019	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSZ1900022	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSZ1900021	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSB1700214	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2018-12-25	view
JYSB1700215	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-04-25	view
JYSB1700217	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-21	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-04-25	view
JYSB1700216	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-01	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-04-25	view